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Abstract
Background: The challenges of conducting research with hard to reach vulnerable groups are particularly pertinent
for people with learning disabilities. Data collection methods for previous cost and cost-effectiveness analyses of
health and social care interventions targeting people with learning disabilities have relied on health care/health
insurance records or data collection forms completed by the service provider rather than by people with learning
disabilities themselves. This paper reports on the development and testing of data collection methods for an
economic evaluation within a randomised controlled trial (RCT) for a supported self-management programme for
people with mild/moderate learning disabilities and type 2 diabetes.
Methods: A case finding study was conducted to identify types of health and social care use and data collection
methods employed in previous studies with this population. Based on this evidence, resource use questionnaires
for completion by GP staff and interviewer-administered participant questionnaires (covering a wider cost
perspective and health-related quality of life) were tested within a feasibility RCT. Interviewer-administered
questionnaires included the EQ-5D-3L (the NICE recommended measure for use in economic evaluation).
Participants were adults > 18 years with a mild or moderate learning disability and type 2 diabetes, with mental
capacity to give consent to research participation.
Results: Data collection for questionnaires completed by GP staff requesting data for the last 12 months proved
time intensive and difficult. Whilst 82.3% (121/147) of questionnaires were returned, up to 17% of service use items
were recorded as unknown. Subsequently, a shorter recall period (4 months) led to a higher return rate but with a
higher rate of missing data. Missing data for interviewer-administered participant questionnaires was > 8% but the
interviewers reported difficulty with participant recall. Almost 60% (48/80) of participants had difficulty completing
the EQ-5D-3L.
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Conclusions: Further investigation as to how service use can be recorded is recommended. Concerns about the
reliability of identifying service use data directly from participants with a learning disability due to challenges in
completion, specifically around recall, remain. The degree of difficulty to complete EQ-5D-3L indicates concerns
regarding the appropriateness of using this measure in its current form in research with this population.
Trial registration: Current Controlled Trials ISRCTN41897033 (registered 21 January 2013).
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Background
It is estimated that there are around 1.2 million people
in the UK with a mild or moderate learning disability
[1]. Learning disability can be defined as the presence of
a significantly reduced ability to understand new or
complex information and to learn new skills combined
with a reduced ability to cope independently [2]. As a
population, people with a learning disability are more
likely to be in poorer health and to die earlier than those
without a learning disability [3, 4]. Disparities in health
and health outcomes for this population have been the
focus of recent NHS policy initiatives, which have placed
addressing poor outcomes and health inequalities for
people with a learning disability at the heart of their
agenda [5]. These disparities can be seen in the higher
prevalence of type 2 diabetes in people with a learning
disability compared to the general population, 9–11 and
4–5%, respectively [6, 7], and higher rates of hospital ad-
missions due to poorly controlled diabetes [6, 8].
There are a number of possible explanations for high
rates of poorly controlled type 2 diabetes in adults with
a learning disability including high prevalence of obesity
and unhealthy diets, prescription medications that in-
crease risk of obesity, reduced self-management skills
and lack of practical support [9–11]. Whilst self-
management of type 2 diabetes is encouraged in the gen-
eral population, its value and cost effectiveness has not
been explored in people with a learning disability.
This paper reports on the development and testing of
data collection methods for an economic evaluation
within a randomised controlled trial (RCT) for a sup-
ported diabetes self-management programme for people
with a mild/moderate learning disability. A full descrip-
tion of the study is reported elsewhere [12], but in brief
the study sought to explore the feasibility of conducting
a definitive phase III randomised controlled trial to
evaluate the clinical and cost-effectiveness of supported
self-management of type 2 diabetes in adults with a mild
or moderate learning disability and consisted of the fol-
lowing: (i) an initial case finding and recruitment study,
(ii) development of materials to implement and evaluate
an RCT of supported self-management, (iii) feasibility
RCT of supported self-management + treatment as usual
(SSM) vs. treatment as usual (TAU). As Fig. 1 shows,
development and testing of data collection methods for
an economic evaluation was undertaken in two phases,
during the case finding study (phase I) and during the
feasibility randomised controlled trial (RCT) (phase II).
Phase I—case finding study; methods for
economic evaluation
The aim of the phase I case finding study was to
identify the different types of health and social care
used by individuals with a mild/moderate learning
disability and type 2 diabetes. This information would
then be used to design a resource use questionnaire
for completion by GP staff using the patient’s record
for use in an economic evaluation of a supported
self-management intervention for this population. In
addition, phase I would identify suitable outcome
measures for such an economic evaluation.
A literature review was undertaken to inform the
choice of outcome measure and the development of the
health care resource use questionnaires to be completed
by GP staff. These health care resource use question-
naires were to be piloted within the phase I case finding
study before further refinement and testing for use in
the phase II feasibility RCT.
Literature review
The aim of the literature review was fourfold: to identify
(i) health and social care resources used by people with
type 2 diabetes and a learning disability within self-
management interventions (including frequency and
drivers of costs) and the methods by which that data
were collected; (ii) health and social care resources used
by the general population of people with type 2 diabetes
within self-management interventions (including fre-
quency and drivers of costs); (iii) health and social care
resources used in other settings by people with a learn-
ing disability and the methods by which that data was
collected; (iv) outcome measures used within any of the
cost-effectiveness analyses identified.
The search strategies comprised index terms, text
words and their synonyms for four concepts: learning
disability, self-care interventions, type 2 diabetes and
costs (or economic evaluations). Three separate searches
were run in EMBASE, MEDLINE and the Cochrane
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Library between May 2013 and February 2014. Searches
used alternative combinations of three of the four con-
cepts in each. The searches were not limited by language
or date of publication. The inclusion criteria were as fol-
lows: cost-effectiveness studies for healthy lifestyle inter-
ventions; cost-effectiveness studies for diabetes self-
management; and studies with costs and/or outcomes
for people with a learning disability. Papers were ex-
cluded in which studies reported in abstract form only,
related to self-monitoring or focussed on pharmaceutical
treatment for diabetes. Titles and abstracts were
reviewed by two people (CH and JOD) and data ex-
tracted using a bespoke data extraction template which
included the type of intervention, duration of the study,
outcome measures used and type of cost data collected.
Development and administration of resource use
questionnaires
Based on information retrieved from the literature review
(see Additional file 1), together with input from the wider
study team, the health care resource use questionnaires to
be completed by GP staff were developed. This question-
naire covered primary and secondary health care use over
a 12-month period and included community-based ser-
vices such as an ophthalmologist, podiatrist and dietician,
i.e. services that people with diabetes are often advised to
attend.
After consent to contact their GP was obtained from
the study participant, the Clinical Trials Research Unit
(CTRU) posted the questionnaire to GP practices. A
cover letter explaining the study and reimbursement for
the time to complete the questionnaire was provided.
The CTRU informed the research team if the question-
naire had not been returned after 6 weeks. Reminders to
complete questionnaires were by way of a series of
emails and unlogged telephone calls by a researcher to
the GP practices. For questionnaires still not returned
after the 6-week reminder, where feasible, the researcher
visited the GP surgery and supported the practice to
complete the questionnaire.
The completeness of the data collected in the ques-
tionnaires was recorded using descriptive statistics, de-
tailing the number and percentage of questionnaires
returned and the number and percentage of missing
items within the returned questionnaires.
Phase I—case finding study; results
The literature review searches identified 1189 unique
references.
Resource use
The first search of evidence of cost-effectiveness analysis
of self-management interventions in people with dia-
betes and a learning disability found no papers that met
the inclusion criteria. The second search, studies of cost-
effectiveness analysis of self-management interventions
in people with diabetes, identified eight studies [13–20]
that met the inclusion criteria (see Additional file 2).
The selected studies were lifestyle modification pro-
grammes and telephone interventions (both automated
and non-automated). The final search for studies detail-
ing costs or costs and outcomes of interventions for
people with a learning disability, identified six studies
[21–26] that met the inclusion criteria (see Add-
itional file 2). Two cost-of-illness studies [22, 24] exam-
ined service use and healthcare costs of people with a
learning disability, giving an overview of the main
drivers in the cost of care for a person with a learning
disability, with hospital-based care, GP, nursing care and
accommodation being the main drivers of service costs.
Cost data were collected using a variety of methods in-
cluding interviews with health workers, standardised
templates for staff, participant questionnaires and par-
ticipant medical records. Each diabetes self-management
intervention included programme costs with staff (e.g.
nurses, counsellors, educators) being the greatest drivers
Fig. 1 Phase I and phase II data collection development
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of cost in relation to intervention delivery. Administra-
tion costs such as telephone charges, printing charges
and translation costs added to the expense of the inter-
ventions. In many of the US studies, patient costs were
not included or included in a generalised form using in-
surance information, with just one study [15] including
participant out-of-pocket costs such as gym member-
ship, exercise equipment and cost of diet change. From
Review (iii), resource use (hospital-based care, GP and
nurse care) and accommodation were found to be the
main drivers identified in relation to the cost-of-illness
studies for people with a learning disability. The UK
studies [21, 22, 25, 26] used modified versions of the Cli-
ent Service Receipt Inventory (CSRI) [27].
Based on the limited data of health and social care use
gleaned from the review in phase I of this study, and in
consultation with the experts on the study team, a re-
source use questionnaire to be completed by GP staff
was developed using a modified version of the CSRI for
distribution to GP practices.
Outcome measures
In respect of outcomes, the included diabetes interven-
tions used clinical marker data such as HbA1C levels,
body mass index (BMI) and risk of cardiovascular dis-
ease; in terms of quality of life measures, the majority of
the diabetes interventions used quality-adjusted life years
(QALYs) [13, 17–20], derived from the EQ-5D-3L or SF-
12. In the four studies involving a cohort of people with
cognitive or learning disability which measured health
outcomes, two studies [23, 25] used activity patterns
such as social interactions; another study [26] measured
health outcomes using an aggression scale and the
QOL-Q; and one cost-effectiveness analysis [21] used
EQ-5D-3L to calculate QALYs.
Previous work has suggested that the SF-36 is promis-
ing for use with people with a learning disability [28];
the shorter SF-12, used in one of the papers identified
[17], uses 12 questions from the SF-36. The EQ-5D-3L
and the Health Utilities Index (HUI) have also been
shown to be superior compared with other preference-
based measures of health for this population [28]. None
of the studies identified in Reviews (ii) and (iii) had used
the HUI. Based on the frequent use of EQ-5D-3L in the
included literature from Review (ii), the EQ-5D-3L was
chosen to be assessed for feasibility as an outcome
measure for any subsequent RCT within phase II.
Data collection experience and missing data results
Between June 2013 and January 2015, a resource use
questionnaire to be completed by GP staff for each con-
sented participant was posted to their GP practice for
completion using their patient record. The question-
naires asked about the services the participant had used
over the previous 12 months. Case finding methods in
phase 1 identified 147 eligible and consenting partici-
pants, of whom 121 (82.3%) had a resource use ques-
tionnaire completed on their behalf by a member of staff
at a GP practice or with support from a researcher. Of
completed questionnaires, missing data for each item
was < 5%; however, items recording service use re-
sponses, whilst not missing, were recorded as unknown
in up to 17% of items. The data collection process for
these questionnaires proved time intensive and difficult.
In some instances, researcher telephone reminders to
encourage completion exceeded nine or more attempts.
Further attempts to contact proved less rewarding with
emails being rarely replied to. Often service uses could
only be accurately counted by opening every document
in the participant’s file to check for referral letters which
had been scanned and saved as attachments in a patient
record. There were cases where staff at practices refused
to complete sections because the process took longer
than they had anticipated. Those practices who did not
want to complete the questionnaire were offered the op-
tion of a research team member visiting the practice to
support them in completing the questionnaire; however,
this offer was only accepted on three occasions.
Resource use
As shown in Table 1, GP and practice nurse visits are
the most frequent resources used. Almost 93% of the
121 participants visited the GP at least once in a 12-
month period and 90% of participants visited the prac-
tice nurse. One in three (34.7%) participants had been to
see a podiatrist and over one quarter (27.3%) had been
to see an ophthalmologist. Over 21% of participants
attended A&E in the 12-month period and 11.6% had
at least one inpatient stay. Services such as dietician,
diabetic clinic, district nurse, and nephrologist were
much less frequently used. Of the 121 questionnaires
received, only three participants (2.5%) had been re-
corded attending a nephrology appointment during a
12-month period.
The questionnaire also included a space to record pre-
scribed diabetes medications. Of the 121 completed
questionnaires, diabetes medication information was
supplied for 61 participants (50.4%). Additional file 3:
Table S3 shows the medication information supplied.
Metformin was the most frequently recorded drug, being
received by over 81% of participants (50/61) for whom
completed questionnaires were returned.
Phase II—feasibility RCT; methods
In addition to the resource use questionnaire to be com-
pleted by GP staff developed for the phase I case finding
study, phase II questionnaires for completion by the
study participants (through interviewer-administration)
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were developed based on the findings from the literature
review (phase I) and input from the study team. A sec-
ondary aim of phase II was to test the data collection
questionnaires for use in a subsequent definitive RCT.
This included an analysis of the acceptability of
interviewer-administered participant questionnaires and
participant-reported outcomes from interviews at base-
line and 6-month follow-up, and an exploratory analysis
of data collected from GP records using a revised ver-
sion of the phase I questionnaire to be completed by GP
staff in order to identify the main drivers of health and
social care cost within the intervention and treatment-
as-usual (TAU) groups.
The resource use questionnaire to be completed by par-
ticipants took a wider, societal perspective including ques-
tions about health care use resource use, employment
status, sick leave, their living situation and out-of-pocket
expenditures incurred as a result of health care admissions
or appointments. Questions were written in plain English
and were phrased in a conversational tone. The inter-
viewers recorded post-interview journals reporting on
their perceptions of the ease of completion. This gave a
more in-depth understanding of the challenges for partici-
pants in responding to the questions, and the influence of
supporters on participant responses. The questionnaires
were analysed using descriptive statistics to assess the level
of completeness of data, categorised into resource use,
employment and accommodation.
In addition to the questionnaire for completion by par-
ticipants, a revised resource use questionnaire was again
sent to GP practices to complete using the patient’s rec-
ord. As concerns were voiced by staff at the GP practices
and study researchers over the time-consuming and
problematic collection process in phase I, for phase II,
there was a change of approach to the collection of
health care resource use data. GP practices were asked
for participants’ resource use relating to a shorter dur-
ation than in phase I (4 months rather than 12 months).
The completion rate improved for phase II, GP practices
were contacted regarding completion after 6 weeks had
passed on just two occasions.
Unit costs were assigned to the data in order to esti-
mate the main drivers of health and social care costs
over a 4-month period for the sample. Unit costs were
obtained from national sources including the Personal
Social Services Research Unit (PSSRU) Costs of Health
and Social Care [29], NHS reference cost database [30]
and the British National Formulary (BNF) [31]. The cost
analysis was based on complete cases only (i.e. question-
naires which had no missing or unknown data).
Based on findings from the literature review in phase
I, the EQ-5D-3L was chosen to be assessed as part of
the phase II feasibility study [32, 33] and included as
part of the interviewer-administered questionnaire. No
changes were made to the text of the EQ-5D-3L; how-
ever, each EQ-5D-3L domain, and associated levels, were
printed on a separate A4 laminated sheet as an interview
aid. The visual analogue scale (VAS) element of the EQ-
5D-3L was not included as the service user involvement
group who work with people with learning disabilities
felt it would be too difficult for participants to under-
stand. This view accords with another study [34].
Phase II—feasibility RCT; results
Participant-reported resource use and wider societal
perspective
Participants were interviewed at baseline and at 6-
month follow-up. Interviews were undertaken between
September 2014 and September 2015. At baseline, 82
participants were interviewed, 40 males and 42 females
and the mean age was 56.4 years; 77 of these partici-
pants were interviewed for a second time at follow-up.
A full description of the complex recruitment process is
reported elsewhere [12].
Accommodation
We asked participants about their living arrangements.
In relation to accommodation type at baseline, 57.3% of
Table 1 Service usage phase I (12 months)
Completed GP questionnaire (n = 121) Yes No Unknown Missing
GP 112 (92.6%) 7 (5.7%) 2 (1.7%) 0 (0.0%)
Practice nurse 109 (90.1%) 10 (8.3%) 1 (0.8%) 1 (0.8%)
District nurse 14 (11.6%) 83 (68.6%) 20 (16.5%) 4 (3.3%)
Diabetic clinic at the hospital 9 (7.4%) 97 (80.2%) 10 (8.3%) 5 (4.1%)
Ophthalmologist 33 (27.3%) 67 (55.4%) 16 (13.2%) 5 (4.1%)
Podiatrist 42 (34.7%) 61 (50.4%) 15 (12.4%) 3 (2.5%)
Dietician 12 (9.9%) 86 (71.1%) 20 (16.5%) 3 (2.5%)
Nephrologist 3 (2.5%) 99 (81.8%) 13 (10.7%) 6 (5.0%)
Inpatient stays 14 (11.6%) 91 (75.2%) 11 (9.1%) 5 (4.1%)
A&E 26 (21.5%) 75 (62.0%) 15 (12.4%) 5 (4.1%)
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participants (47/82) lived in domestic housing; 15.9% (13/
82) lived in sheltered housing; 18.3% (15/82) lived in a
shared supported house. At follow-up, 50.6% of participants
(39/77) lived in domestic housing, 16.9% (13/77) lived in
sheltered housing and 26% (20/77) lived in a shared sup-
ported house. There was only one missing observation
across the sample for this question; however, interviewer
notes highlight the difficulty in being able to categorise
their residence; for the 77 participants interviewed at
follow-up, over 40% changed their answer from the one
they gave at baseline (see Additional file 3: Table S4).
Employment
As shown in Table 2, over half of the participants (base-
line 54.9% (45/82); follow-up 51.9% (40/77)) were ‘At
home, unable to work’. At each time point, almost one
fifth of participants (baseline 17.1% (14/82); follow-up
19.5% (15/77)) classed themselves as ‘Retired’. At base-
line, 14.6% of participants (12/82) were in employment,
and at follow-up, 10.4% (8/77) were in employment.
There was missing data from just one participant; how-
ever, interviewers recorded 31 participants (37.8%) hav-
ing difficulty categorising their employment status at
baseline. The employment status changed for 39 of the
77 participants (50.6%) who completed questionnaires
from baseline to follow-up, with 19 of these (24.7%)
appearing to move in both directions between ‘Retired’
and ‘At home and unable to work’.
Participants were asked if they had been off work due
to illness in the last 4 weeks. Three participants (3.7%)
indicated they had at baseline, and just one participant
indicated sick leave at follow-up. All sick leave recorded
was between 1 and 2 days.
Participant-reported service use
Participants were asked to recall the health and social
care services they had used in the last 4 weeks. The re-
sults are shown in Tables 3 and 4.
Very little missing data (< 8%) was reported at baseline
and follow-up; however, the interviewers did report a
number of respondents having difficulty recalling their
health and social care use (62% at baseline and 41% at
follow-up). The recall time posed particular problems
with supporter clarification required:
- “Had to explore if the visit had been in the last four
weeks, since participant also mentioned two visits
before Christmas.” (#75)
When asked about hospitals stays, some participants
would report stays which were found to be from a
long time ago despite the researcher defining the
timeframe we were interested in. Responses to ques-
tions about changes in medication were complicated
to interpret as people often did not know what they
were taking or only knew medication by shape and/or
size of tablet:
- “Person reported hospital stay that happened a long
time ago…..Participant knew she took medication and
told researcher what tablet was like. Initially suggested
that medication had changed but when researcher
enquired further it seemed that it had not.” (#81)
Paid support workers often had files for a person
and could look up hospital visits and confirm or deny
self-reported information. Some participants knew
they had made some use of the GP but not the num-
ber of times; others may have answered positively to
hospital use but have been thinking of visits outside
the time frame:
- “Could recall services used but did not know how
many times. Participant said had been to hospital in
the last six months but on checking with supporter,
she had not.” (#344)
Table 2 Baseline service use (1 month)
Service (n = 82) Yes No Don’t know Missing Mean times Min Max
Saw GP at the surgery 40 (48.8%) 40 (48.8%) 2 (2.4%) 0 (0.0%) 1.35 1 3
Saw GP at home 1 (1.2%) 79 (96.3%) 2 (2.4%) 0 (0.0%) 3.00 3 3
Saw a nurse 4 (4.9%) 75 (91.5%) 3 (3.7%) 0 (0.0%) 2.25 1 3
Phoned a nurse for advice 32 (39.0%) 48 (58.5%) 2 (2.4%) 0 (0.0%) 1.55 1 4
Got a repeat prescription 1 (1.2%) 79 (96.3%) 2 (2.4%) 0 (0.0%) 1.00 1 1
Got meals on wheels 51 (62.2%) 25 (30.5%) 6 (7.3%) 0 (0.0%) 1.32 1 4
Home help came around 0 (0.0%) 80 (97.6%) 2 (2.4%) 0 (0.0%) 0.00 0 0
Saw social worker 14 (17.1%) 67 (81.7%) 1 (1.2%) 0 (0.0%) 7.45 1 28
Been to A&E 4 (4.9%) 77 (93.9%) 0 (0.0%) 1 (1.2%) 1.00 1 1
Stayed in hosp. overnight 2 (2.4%) 79 (96.3%) 0 (0.0%) 1 (1.2%) 1.5 1 2
Outpatient 31 (37.8%) 50 (61.0%) 1 (1.2%) 0 (0.0%) 1.452 1 4
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Self-reported medication
At the follow-up interview, participants were asked if
their medication had changed over the past 6 months.
Just seven participants (9.1%) indicated it had; four par-
ticipants (5.2%) indicated a change in frequency, and
three participants (3.9%) indicated the type of medica-
tion had changed. This data could not be verified.
GP practice-reported resource use
In order to identify the main drivers of health and social
care cost over a 4-month period, we assigned unit costs
to each service use (Table 4). Data was not available for
the length of stay in hospital; therefore, each recorded
inpatient stay was assumed to be a short stay. The cost
analysis was based on complete cases only (i.e. question-
naires which had no missing or unknown data), this re-
duced our sample from 70 (85.4% of recruited
participants) to 55 (67.1% of recruited participants).
As shown in Table 5 below, GP and practice nurse
visits were the most frequent resources used. Over 77%
of the 70 participants visited the GP at least once in a 4-
month period and 60% of participants visited the
practice nurse. Again, visits by participants to see a
podiatrist were close to 30% with 10% having been to
see an ophthalmologist. Over 14% of participants
attended A&E in the 4-month period and 10% had at
least one inpatient stay. Services such as dietician, dia-
betic clinic, district nurse, and nephrologist were much
less frequently used. From 70 questionnaires received,
only one participant had recorded attending a nephrol-
ogy appointment during a 4-month period.
An exploratory analysis was undertaken of the main
drivers of cost by assigning unit costs to the data
recorded on the questionnaires completed by GP staff,
excluding medications (Table 6).
Medications
The questionnaire completed by GP staff also included a
space to record prescribed diabetes medications.
Additional file 3: Table S5 highlights the diabetes medi-
cations prescribed to the participants and the cost for
4 months.
Additional file 3: Table S6 highlights the medication
use of the 55 participants with complete information.
Table 3 Current employment situation
Employment status Baseline Follow-up
Working full time 3 (3.7%) 4 (5.2%)
Working part time 9 (11.0%) 4 (5.2%)
Unemployed and looking for work 0 (0.00%) 1 (1.3%)
At home/unemployed and not looking for work 1 (1.2%) 0 (0.0%)
At home, unable to work 45 (54.9%) 40 (52.0%)
Volunteer 7 (8.5%) 10 (13.0%)
Student 1 (1.2%) 0 (0.0%)
Retired 14 (17.1%) 15 (19.5%)
Other 1 (1.2%) 3 (3.9%)
Missing 1 (1.2%) 0 (0.0%)
Total 82 (100.0%) 77 (100.0%)
Table 4 Follow-up service use (1 month)
Service (n = 77) Yes No Don’t know Missing Mean times Min Max
Saw GP at the surgery 26 (33.8%) 47 (61.0%) 4 (5.2%) 0 (0.0%) 1.44 1 5
Saw GP at home 3 (3.9%) 74 (96.1%) 0 (0.0%) 0 (0.0%) 2.00 1 3
Saw a nurse 13 (16.9%) 64 (83.1%) 0 (0.0%) 0 (0.0%) 1.92 1 5
Phoned a nurse for advice 23 (29.9%) 50 (64.9%) 3 (3.9%) 1 (1.3%) 1.36 1 6
Got a repeat prescription 1 (1.3%) 73 (94.8%) 1 (1.3%) 2 (2.6%) 3.00 3 3
Got meals on wheels 73 (94.8%) 4 (5.2%) 0 (0.0%) 0 (0.0%) 1.00 1 1
Home help came around 0 (0.0%) 77 (100.0%) 0 (0.0%) 0 (0.0%) 0.00 0 0
Saw social worker 14 (18.2%) 61 (79.2%) 1 (1.3%) 1 (1.3%) 8.75 1 28
Been to A&E 4 (5.2%) 72 (93.5%) 0 (0.0%) 1 (1.3%) 2.00 1 5
Stayed in hosp. overnight 3 (3.9%) 73 (94.8%) 0 (0.0%) 1 (1.3%) 4.00 1 10
Outpatient 16 (20.8%) 60 (77.9%) 1 (1.3%) 0 (0.0%) 1.40 1 4
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Metformin, again, remains the most frequently used
drug, being received by the majority of participants.
Outcomes
In order to calculate QALYs, the feasibility of using
the EQ-5D-3L in a larger trial was explored. Table 7
provides a summary of participant-reported EQ-5D-3L
over time.
The EQ-5D was incomplete for two participants at base-
line and one out of 77 participants with a follow-up visit.
The average absolute difference between baseline and
follow-up was 0.0042 (SD 0.2893). Despite few missing
data, interviewers reported that 60% of participants (48/
80) at baseline and 53.9% of participants (41/76) at follow-
up had some level of difficulty completing the measure.
The most important contextual area was the role played
by the supporter in the interview process. Although 25%
of participants (20/80) did not have a supporter present,
for those with a supporter present interviewers recorded
supporter intervention on occasion (for 11% of partici-
pants at baseline and 14.5% at follow-up) providing ex-
planation of the questions when required, and sometimes
when not. Supporters contextualised the question for the
respondent, answering questions on the respondent’s be-
half and sometimes succeeding in persuading respondents
to change answers to match their own perceptions of the
respondent’s health state. In the case of the latter, it was
clear that often the supporter did not agree with the level
chosen by the participant. On occasion, the supporter
being present was enough to influence the participant.
Researchers recorded the following observation:
- “Participants answers were contradicted by the
supporter at first. This led to participant asking first
what supporter would say before giving own answer.
I tried to capture participants own answers.” (#91)
Table 5 Service usage phase II: (4-month period)
Completed GP questionnaires: (n = 70) Yes No Unknown Missing
GP 54 (77.1%) 15 (21.4%) 0 (0.0%) 1 (1.4%)
Practice nurse 42 (60.0%) 25 (35.7%) 0 (0.0%) 3 (4.3%)
District nurse 4 (5.7%) 58 (82.9%) 4 (5.7%) 4 (5.7%)
Diabetic clinic at the hospital 3 (4.3%) 60 (85.7%) 1 (1.4%) 6 (8.6%)
Ophthalmologist 7 (10.0%) 55 (78.6%) 2 (2.9%) 6 (8.6%)
Podiatrist 20 (28.6%) 42 (60.0%) 3 (4.3%) 5 (7.1%)
Dietician 3 (4.3%) 60 (85.7%) 1 (1.4%) 6 (8.6%)
Nephrologist 1 (1.4%) 64 (91.4%) 0 (0.0%) 5 (7.1%)
Diabetes educational course 0 (0.0%) 61 (87.1%) 3 (4.3%) 6 (8.6%)
Chronic illness course 2 (2.9%) 59 (84.3%) 3 (4.3%) 6 (8.6%)
Inpatient stays 7 (10.0%) 59 (84.3%) 1 (1.4%) 3 (4.3%)
A&E 10 (14.3%) 55 (78.6%) 1 (1.4%) 4 (5.7%)
Table 6 Service use: costs (assuming inpatient short stays) for complete cases for 4 months
Variable n Mean no. of visits Mean cost (£) Min cost (£) Max cost (£)
GP 55 3.13 143.85 0.00 1058.00
Practice nurse 55 1.18 16.18 0.00 95.83
District nurse 55 0.05 1.40 0.00 51.48
Diabetic clinic at the hospital 55 0.04 3.82 0.00 105.00
Ophthalmologist 55 0.13 9.04 0.00 142.00
Podiatrist 55 0.36 11.64 0.00 64.00
Dietician 55 0.05 2.02 0.00 37.00
Nephrologist 55 0.00 0.00 0.00 0.00
Diabetes educational course 55 0.00 0.00 0.00 0.00
Chronic illness course 55 0.04 2.36 0.00 65.00
Inpatient stays 55 0.13 77.76 0.00 1222.00
A&E 55 0.16 29.45 0.00 360.00
Total 55 5.27 321.89 0.00 1947.00
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The linguistic challenges and the role played by the
supporter were not mutually exclusive and often over-
lapped. At baseline, 28.8% of participants (23/80) were
assisted by a supporter; at follow-up, this figure de-
creased to 21.1% (16/76).
Discussion
Based on evidence from the literature and expert advice
from the research team, we developed two data collec-
tion instruments relating to participants’ health and so-
cial care use, assessing two methods of data collection.
Resource use questionnaires (covering participants’
health and social care) completed by GP staff and
interviewer-administered participant questionnaires
(covering a wider cost perspective and health-related
quality of life using the EQ-5D-3L).
The analysis of the results from the phase I resource use
questionnaire completed by GP staff highlights the high
use of primary care services such as GP and nurse care in
comparison with hospital-based care. Whilst 82.3% of the
questionnaires were returned and with few missing items
(< 5% missing), there was however a high level of service
use recorded as unknown (which could therefore be con-
sidered to be missing data). This highlights the challenge
of data collection in primary care. Completion of the re-
source use questionnaires by GP staff was time consuming
and problematic in respect of the intensity of follow-up re-
minders required to achieve the return rate of over 82%
(including researchers helping with completion in the GP
surgeries). Potential reasons for the time-consuming
nature of the questionnaires and the missing data was the
12-month time period over which resource usage was
requested and the GP practice inability or unwillingness
to complete the task.
In phase II, the time period over which resource usage
was collected from GP records was decreased to
4 months, to ease completion. When unit costs were ap-
plied, the main drivers of cost were GP care and
hospital-based care (A&E and inpatient stays). The types
of services used and the main drivers of cost are similar
to findings from the literature review [19–22, 25, 26].
The time spent in hospital was not recorded; therefore,
each inpatient stay is assumed to be a short stay which
may underestimate the cost of this resource use. In
addition, it was not possible to differentiate between
face-to-face and telephone contacts from the patient’s
records; face-to-face contact was assumed which may
have overestimated the time and cost.
The intensity of reminders and GP visits to assist com-
pletion in case finding was not replicated in the feasibil-
ity RCT, and in fact, the return rate increased in the
second phase of the study. It is not possible to say
whether this was because the surgeries became more
adept at completion over time or whether it was because
the questionnaires were asking about a shorter timespan
in the RCT. There were less data reported as ‘unknown’;
however, more data was reported as missing. Data on
services provided outside the GP surgery team, some of
which are part of the Diabetes Annual Care Review, e.g.
podiatrist, which were recorded as unknown and missing
remained relatively high. If GP records were to be used
in future studies with this population, methods to re-
trieve data on community service use would also need to
be factored into the design. The only service not re-
corded as being used by any of the participants was the
diabetes educational course despite being part of recom-
mended first-line treatment of type 2 diabetes in adults
[35]. Further investigation of how these community-
based services may be captured is required.
Despite the difficulty in collecting data directly from
GP records, it appears to be a more reliable method than
collecting the information from participants themselves.
Participants were asked to recall their recent health care
use at baseline and follow-up. Interviewers recorded a
high occurrence of difficulty with this question (61% at
baseline). Rephrasing of questions (e.g. 4 weeks/1 month)
and supporter clarification was required. Such a high de-
gree of difficulty with recall indicates concerns about
collecting resource use data directly from participants.
Interviewers classified accommodation and employment
subjectively and changed their interpretation of the re-
sponse (or it was a different interviewer). A finding
would be that these categories need to be better defined
for interviewers.
The solution as to how to collect resource use data for
this population could lie in the use of electronic records,
such as Patient Level Information and Costing System
(PLICS), as coverage in the UK increases. Providing a
central data team with specific data extraction queries
could make the data collection process more efficient.
These methods bring their own challenges, not least in
how to collect out-of-pocket costs for lifestyle change in-
terventions (e.g. cost of changes in diet and exercise)
and the costs associated with self-management itself. Ac-
commodation and employment status data may also not
be included within GP records.
Table 7 EQ-5D-3L by time point
EQ-5D-3L n Mean SD Min Lower quartile Median Upper quartile Max
Baseline 80 0.6668 0.2875 0.239 0.603 0.725 0.848 1
Follow-up 76 0.6641 0.3458 0.239 0.431 0.788 1 1
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There was almost no missing EQ-5D-3L data re-
ported with only two participants not completing this
part of the questionnaire at baseline and one not
completing at follow-up. This was most likely because
it was interviewer-administered. Despite high comple-
tion rates, participants still experienced difficulty an-
swering, with up to 60% being considered to have
some level of difficulty with the EQ-5D-3L questions
and requiring assistance from the researcher or sup-
porter. The main difficulty experienced was with
wording and understanding terms in the questions;
rephrasing and explanations of terms helped with
completion; however, this is discouraged by the
creators of the EQ-5D as it invalidates the measure.
Supporters intervened often, sometimes correcting
participant’s answers, even if the participant did not
appear to have trouble with the question. Participants
on occasion disagreed with supporters, placing a dif-
ferent value on their own health.
Conclusion
Data collection methods for a future economic evalu-
ation were developed, and their feasibility was tested
during this study. In the testing phase (feasibility RCT),
there was a higher return rate of the resource use ques-
tionnaire from GP practices than had been seen in the
development phase (phase I). There were relatively high
rates of ‘unknown’ answers for community-provided
care than for care provided within the GP surgery or by
the GP team; therefore, a requirement for further inves-
tigation as to how community team service use can be
recorded remains, as does sustaining the high return rate
from GP practices.
In respect of the participant-completed resource use
questionnaires, there were challenges in completion,
specifically around the time particular events hap-
pened and recall more generally. Difficulty with recall
is common in people who have a learning disability
[36], and there are concerns about the reliability of
identifying service use data for use in economic eval-
uations directly from the participants with a learning
disability themselves.
In respect of assessment of quality of life, although
rephrasing and provision of explanations facilitated
completion of EQ-5D-3L, a substantial proportion of
participants had difficulty in understanding the ques-
tions. The high degree of difficulty experienced indi-
cates concerns regarding the appropriateness of
using this measure in its current form in research
with this population. Further research into the lan-
guage, format and process of completion of the EQ-
5D-3L for participants with a learning disability is
recommended.
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